oseltamivir has been researched along with vx-787 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandarage, UK; Bennani, YL; Bennett, HB; Bethiel, RS; Boyd, MJ; Bral, C; Byrn, RA; Charifson, PS; Clark, MP; Court, JJ; Davies, I; Deng, H; Dorsch, WA; Duffy, JP; Farmer, LJ; Gao, H; Germann, U; Gu, W; Jackson, K; Jacobs, DH; Jacobs, M; Jiang, M; Jones, SM; Kennedy, JM; Ledeboer, MW; Ledford, B; Leeman, JR; Liang, J; Maltais, F; McNeil, C; Memmott, C; Murcko, M; Nezami, A; Nti-Addae, K; Perola, E; Rijnbrand, R; Salituro, FG; Taylor, WP; Tsai, A; Wang, T; Wannamaker, MW; Zhang, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barnard, DL; Jones, SM; Smee, DF | 1 |
| Deleu, S; Hillewaert, V; Hoetelmans, RMW; Kakuda, TN; Leopold, L; Lwin, A; Spittaels, K; Vercauteren, JJ | 1 |
| Anderson, D; Finberg, RW; Fleischhackl, R; Kauffman, RS; Kosoglou, T; Lanno, R; Leopold, L; van Duijnhoven, W; Vingerhoets, J | 1 |
| Martin-Loeches, I; O'Sullivan, S; Rodriguez, A; Torres, A | 1 |
| Anderson, D; Deleu, S; Hallouin-Bernard, MC; Ison, MG; Kosoglou, T; Leopold, L; Nilsson, AC; O'Neil, B; Rossenu, S; Torres, A; Van Dromme, I; van Duijnhoven, W; Vingerhoets, J; Wilburn, JM | 1 |
| Anderson, D; De Meyer, S; Leopold, L; Van Dromme, I; van Duijnhoven, W; Vingerhoets, J | 1 |
1 review(s) available for oseltamivir and vx-787
| Article | Year |
|---|---|
Influenza management with new therapies.
Topics: Adrenal Cortex Hormones; Amides; Antiviral Agents; Critical Care; Critical Illness; Dibenzothiepins; Enzyme Inhibitors; Humans; Influenza, Human; Morpholines; Neuraminidase; Oseltamivir; Pyrazines; Pyridines; Pyridones; Pyrimidines; Pyrroles; Respiration, Artificial; Triazines; Zanamivir | 2020 |
4 trial(s) available for oseltamivir and vx-787
| Article | Year |
|---|---|
Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy v
Topics: Adolescent; Adult; Antiviral Agents; Area Under Curve; Cross-Over Studies; Diarrhea; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Oseltamivir; Pyridines; Pyrimidines; Pyrroles; Time Factors; Young Adult | 2018 |
Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
Topics: Acute Disease; Adult; Antiviral Agents; Diarrhea; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Oseltamivir; Pyridines; Pyrimidines; Pyrroles; Time Factors; Viral Load; Viral Proteins; Virus Shedding | 2019 |
A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Humans; Influenza, Human; Middle Aged; Oseltamivir; Pyridines; Pyrroles; Treatment Outcome; Young Adult | 2022 |
Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study.
Topics: Adult; Antiviral Agents; Genotype; Humans; Influenza A virus; Influenza, Human; Oseltamivir | 2023 |
3 other study(ies) available for oseltamivir and vx-787
| Article | Year |
|---|---|
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
Topics: Administration, Oral; Animals; Antiviral Agents; Aza Compounds; Biological Availability; Dogs; Drug Resistance, Viral; Indoles; Influenza A virus; Madin Darby Canine Kidney Cells; Male; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Orthomyxoviridae Infections; Rats; RNA-Dependent RNA Polymerase; Species Specificity; Stereoisomerism; Structure-Activity Relationship; Viral Proteins; Virus Replication | 2014 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
Topics: Animals; Antiviral Agents; Drug Discovery; Drug Therapy, Combination; Indoles; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Lung; Mice; Orthomyxoviridae Infections; Oseltamivir; Pyridines; Pyrimidines; Pyrroles; Viral Load; Virus Replication | 2016 |